Statistics
Publications
6
Citations
2.8K
H-Index
6
Active since
2004
Affiliations
Eli Lilly (United States)(Current)
Amy Ford is an author at Eli Lilly (United States) specializing in biochemistry, sepsis, and transgenic mice.
Publications per year
2004–2014
6
6
FGF-21 as a novel metabolic regulator
Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester et al. · Journal of Clinical Investigation · 2005 · 2.1K citations · Full text
Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
Alexei Kharitonenkov, John M. Beals, Radmila Micanovic et al. · PLoS ONE · 2013 · 165 citations · Full text
Pharmacy, Biochemistry, Pharmacology +17
A study of symptoms described by ovarian cancer survivors
Chara Stavraka, Amy Ford, Sadaf Ghaem‐Maghami et al. · Gynecologic Oncology · 2011 · 94 citations
Medicine, Gynecology, Oncology +12
Josef G. Heuer, Dianna L. Bailey, Ganesh R. Sharma et al. · Journal of Surgical Research · 2004 · 32 citations
Agriculture, Nutrition, Surgery +13
1–5 of 6